1-3 of 3
Fabio Facchetti
Close
Sort by
Journal Articles

MYC rearrangements in HIV-associated large B-cell lymphomas: EUROMYC, a European retrospective study

Chiara Pagani, Chiara Rusconi, Alessia Dalla Pria, Emanuele Ravano, Philipp Schommers, Mariana Bastos-Oreiro, Luisa Verga, Guido Gini, Michele Spina, Luca Arcaini, Sara Steffanoni, Davide Dalu, Lara Crucitti, Luisa Lorenzi, Piera Balzarini, Chiara Cattaneo, Lucia Bongiovanni, Andreas Rosenwald, Fabio Facchetti, Mark Bower, Andrés J. M. Ferreri, Giuseppe Rossi, Alessandra Tucci, Alessandro Re
Journal: Blood Advances
Blood Adv (2024) 8 (4): 968–977.
https://doi.org/10.1182/bloodadvances.2023010704
Published: 2024
Journal Articles

Safety and efficacy of a dose-dense short-term therapy in patients with MYC-translocated aggressive lymphoma

Andrés J. M. Ferreri, Piera Angelillo, Federico Erbella, Chiara Cattaneo, Luisa Verga, Arben Lleshi, Bernardino Allione, Maurilio Ponzoni, Fabio Facchetti, Chiara Pagani, Marco Foppoli, Lorenza Pecciarini, Marianna Sassone, Sara Steffanoni, Elena Flospergher, Giuseppe Rossi, Michele Spina, Alessandro Re
Journal: Blood Advances
Blood Adv (2022) 6 (22): 5811–5820.
https://doi.org/10.1182/bloodadvances.2022007475
Published: 2022
Journal Articles

Blastic plasmocitoid dendritic cell neoplasm with leukemic spread: a GIMEMA survey

Caterina Giovanna Valentini, Alfonso Piciocchi, Fabio Facchetti, Fabio Guolo, Alessandro Pulsoni, Marco Vignetti, Livio Pagano
Journal: Blood Advances
Blood Adv (2021) 5 (24): 5608–5611.
https://doi.org/10.1182/bloodadvances.2021005802
Published: 2021